Lunai Bioworks
LNAI
32 hedge funds and large institutions have $10.2M invested in Lunai Bioworks in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 12 closing their positions.
177% more call options, than puts
Call options by funds: $205K | Put options by funds: $74K
0.03% less ownership
Funds ownership: 0.06% → 0.04% (-0.03%)
14% less funds holding
Funds holding: 37 → 32 (-5)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
23% less capital invested
Capital invested by funds: $13.3M → $10.2M (-$3.04M)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$1.55M |
| 2 |
Morgan Stanley
New York
|
+$719K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$363K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$191K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$144K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$7.71M |
| 2 |
Millennium Management
New York
|
-$580K |
| 3 |
VF
Virtu Financial
New York
|
-$338K |
| 4 |
BlackRock
New York
|
-$289K |
| 5 |
E
Ergoteles
New York
|
-$238K |
LNAI Hedge Fund Activity: Q3 2021 in Review
32 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2021, worth a combined $10.2M — down 23% from $13.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of LNAI and 7 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 8 added.
The largest buyer was Invesco, opening a new position worth an estimated $1.55M. The largest seller was Sabby Management, cutting an estimated $7.71M.
- 32 institutional investors held Lunai Bioworks (LNAI) as of Q3 2021, down from 37 in Q2 2021.
- Funds reported $10.2M of Lunai Bioworks stock for Q3 2021, down 23% quarter-over-quarter.
- 7 funds opened new Lunai Bioworks positions in Q3 2021 and 12 closed out, a net change of -5 holders.
- The largest Lunai Bioworks buyer in Q3 2021 was Invesco, an estimated $1.55M added.
- The largest Lunai Bioworks seller in Q3 2021 was Sabby Management, an estimated $7.71M sold.
Based on aggregated 13F filings for Q3 2021.